School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Int J Mol Sci. 2021 Dec 28;23(1):314. doi: 10.3390/ijms23010314.
Protein arginylation, mediated by arginyltransferase ATE1, is a posttranslational modification of emerging biological importance that consists of transfer of the amino acid Arg from tRNA to protein and peptide targets. ATE1 can bind tRNA and exhibits specificity toward particular tRNA types, but its dependence on the availability of the major components of the arginylation reaction has never been explored. Here we investigated key intracellular factors that can potentially regulate arginylation in vivo, including several tRNA types that show strong binding to ATE1, as well as availability of free Arg, in an attempt to identify intracellular rate limiting steps for this enzyme. Our results demonstrate that, while modulation of tRNA levels in cells does not lead to any changes in intracellular arginylation efficiency, availability of free Arg is a potentially rate-limiting factor that facilitates arginylation if added to the cultured cells. Our results broadly outline global pathways that may be involved in the regulation of arginylation in vivo.
蛋白质精氨酸化,由精氨酸转移酶 ATE1 介导,是一种新兴的具有重要生物学意义的翻译后修饰,它包括将氨基酸 Arg 从 tRNA 转移到蛋白质和肽靶标上。ATE1 可以结合 tRNA,并对特定的 tRNA 类型表现出特异性,但它对精氨酸化反应的主要成分的可用性的依赖性从未被探索过。在这里,我们研究了潜在的可调节体内精氨酸化的关键细胞内因素,包括几种与 ATE1 结合能力较强的 tRNA 类型,以及游离 Arg 的可用性,试图确定该酶的细胞内限速步骤。我们的结果表明,尽管细胞内 tRNA 水平的调节不会导致细胞内精氨酸化效率发生任何变化,但游离 Arg 的可用性是一个潜在的限速因素,如果添加到培养的细胞中,它可以促进精氨酸化。我们的结果广泛概述了可能参与体内精氨酸化调节的全局途径。